Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 2, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Predictive markers for normal tissue reactions: fantasy or reality?

M Fernet1, J Hall

  • 1Institut Curie-recherche, centre universitaire, bâtiments 110-112, 91405 Orsay, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|August 30, 2008
PubMed
Summary

Understanding genetic factors in radiation sensitivity is crucial. Research is advancing predictive assays and markers for normal tissue reactions, aiding personalized radiation therapy and reducing toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of CD40-mediated endothelial cell activation with antisense oligonucleotides.

Transplantation·2002
Same author

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.

Oncogene·2001
Same author

Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotides.

Anti-cancer drug design·2001
Same author

Health services research in Australia.

Australian health review : a publication of the Australian Hospital Association·2001
Same author

Environmental causes of human cancers.

European journal of cancer (Oxford, England : 1990)·2001
Same author

Biogeography and ecological setting of Indian Ocean hydrothermal vents.

Science (New York, N.Y.)·2001

Area of Science:

  • Radiation oncology
  • Genetics
  • Molecular biology

Background:

  • Interpatient variability in normal tissue reactions to radiation therapy is significant.
  • Genetic determinants and molecular mechanisms of radiation sensitivity are not well understood.
  • Predictive assays and markers for normal tissue reactions are still developing.

Purpose of the Study:

  • To review the current state of predictive assays and markers for normal tissue reactions in radiation oncology.
  • To highlight progress in identifying genetic and molecular predictors of radiation sensitivity and toxicity.
  • To discuss future directions for marker discovery and validation.

Main Methods:

  • Review of existing literature on predictive assays for normal tissue reactions.

More Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

Related Experiment Videos

Last Updated: Jul 2, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

  • Analysis of studies identifying genetic markers (e.g., gene expression, single nucleotide polymorphisms) and serum markers.
  • Discussion of challenges and opportunities in marker validation and clinical implementation.

    • Main Results:

    • T-lymphocyte radiation-induced apoptosis assay shows promise for predicting late toxicity.
    • An 18-gene classifier identified patients at high/low risk for radiation-induced fibrosis.
    • Serum markers show potential for predicting acute and late pulmonary toxicity.
    • Few genetic predictive markers for normal tissue reactions have been validated.

    Conclusions:

    • Predictive assays for normal tissue reactions are advancing, with some assays showing potential for clinical utility.
    • Identification of genes involved in fibrotic processes and potential serum markers for pulmonary toxicity are key findings.
    • International collaboration and technological advancements are expected to accelerate the discovery and validation of genetic markers for radiation sensitivity.